Latest Breaking News On - ஸ்க் ஹிஸ்காக் நிறுவனம் - Page 1 : comparemela.com

Rory Hunter, portfolio manager, said Australian medical technology was among the best in the world and the fund would offer investors access to high quality growth companies. “Australia s history of medical breakthroughs includes penicillin, the bionic ear, ultrasounds, spray-on skin, and the cervical cancer vaccine,” Hunter said. “In addition, there are many research facilities in Australia which are recognised as medical centres of excellence at a global level. “Investors will also benefit from several tailwinds that are driving innovation and growth in medical research and technology.” The fund would be run by the SGH emerging companies team and guided by the SGH medical technology advisory board, which was comprised of: 

New zealandStephen hiscockHamish tadgellMark cookSam lanyonRory hunterBrenda shanahanClinuvel pharmaceuticalsSt vincent medical research instituteUniversity of melbourneSg hiscock companyZealand association of neurologistsAitkenhead centre for medical discoveryGraeme clarke institute for biomedical engineeringMedical research instituteAitkenhead centre